Key result
Angiotensin II acts as a neuromodulatory peptide and co-transmitter in the peripheral autonomic and sensory nervous systems, representing a potential new target for cardiovascular therapies.
This review highlights the emerging role of angiotensinergic neurotransmission in the autonomic nervous system as a potential therapeutic target for cardiovascular diseases such as hypertension, heart failure, and arrhythmias.
May support angiotensinergic neurotransmission as a novel autonomic target in hypertension and heart failure; leaves open clinical translation pending trials.
Angiotensin (Ang) II has for long been identified as a neuropeptide located within neurons and pathways of the central nervous system involved in the control of thirst and cardio-vascular homeostasis. The presence of Ang II in ganglionic neurons of celiac, dorsal root, and trigeminal ganglia has only recently been described in humans and rats. Ang II-containing fibers were also found in the mesenteric artery and the heart, together with intrinsic Ang II-containing cardiac neurons. Ganglionic neurons express angiotensinogen and co-localize it with Ang II. Its intraneuronal production as a neuropeptide appears to involve angiotensinogen processing enzymes other than renin. Immunocytochemical and gene expression data suggest that neuronal Ang II acts as a neuromodulatory peptide and co-transmitter in the peripheral autonomic, and also sensory nervous system. Neuronal Ang II probably competes with humoral Ang II for effector cell activation. Its functional role, however, still remains to be determined. Angiotensinergic neurotransmission in the autonomic nervous system is a potential new target for therapeutic interventions in many common diseases such as essential hypertension, heart failure, and cardiac arrhythmia.
No takes yet. Share an insight, caveat, or question.
Jürgen Bohlender (2012) conducted a review in Autonomic nervous system physiology. Angiotensin II was evaluated. Angiotensin II acts as a neuromodulatory peptide and co-transmitter in the peripheral autonomic and sensory nervous systems, representing a potential new target for cardiovascular therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: